120 related articles for article (PubMed ID: 15922632)
1. Additive effects of ziprasidone and D,L-sotalol on the action potential in rabbit Purkinje fibres and on the hERG potassium current.
Ducroq J; Printemps R; Le Grand M
J Pharmacol Toxicol Methods; 2005; 52(1):115-22. PubMed ID: 15922632
[TBL] [Abstract][Full Text] [Related]
2. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
[TBL] [Abstract][Full Text] [Related]
3. Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve.
Vormberge T; Hoffmann M; Himmel H
J Pharmacol Toxicol Methods; 2006; 54(2):130-40. PubMed ID: 16757186
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological effects of the anti-cancer drug lapatinib on cardiac repolarization.
Lee HA; Kim EJ; Hyun SA; Park SG; Kim KS
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):614-8. PubMed ID: 20406211
[TBL] [Abstract][Full Text] [Related]
5. Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart.
Guérard NC; Traebert M; Suter W; Dumotier BM
J Pharmacol Toxicol Methods; 2008; 58(1):32-40. PubMed ID: 18582585
[TBL] [Abstract][Full Text] [Related]
6. I(Kr) vs. I(Ks) blockade and arrhythmogenicity in normoxic rabbit Purkinje fibers: does it really make a difference?
Puddu PE; Legrand JC; Sallé L; Rouet R; Ducroq J
Fundam Clin Pharmacol; 2011 Jun; 25(3):304-12. PubMed ID: 21241363
[TBL] [Abstract][Full Text] [Related]
7. Choice of cardiac tissue in vitro plays an important role in assessing the risk of drug-induced cardiac arrhythmias in human: beyond QT prolongation.
Lu HR; Vlaminckx E; Gallacher DJ
J Pharmacol Toxicol Methods; 2008; 57(1):1-8. PubMed ID: 17964190
[TBL] [Abstract][Full Text] [Related]
8. Block of hERG channel by ziprasidone: biophysical properties and molecular determinants.
Su Z; Chen J; Martin RL; McDermott JS; Cox BF; Gopalakrishnan M; Gintant GA
Biochem Pharmacol; 2006 Jan; 71(3):278-86. PubMed ID: 16325148
[TBL] [Abstract][Full Text] [Related]
9. Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential.
Himmel HM
J Pharmacol Toxicol Methods; 2007; 56(2):145-58. PubMed ID: 17590357
[TBL] [Abstract][Full Text] [Related]
10. Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization.
Terrar DA; Wilson CM; Graham SG; Bryant SM; Heath BM
J Pharmacol Toxicol Methods; 2007; 56(2):171-85. PubMed ID: 17596973
[TBL] [Abstract][Full Text] [Related]
11. The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block.
Martin RL; McDermott JS; Salmen HJ; Palmatier J; Cox BF; Gintant GA
J Cardiovasc Pharmacol; 2004 Mar; 43(3):369-79. PubMed ID: 15076220
[TBL] [Abstract][Full Text] [Related]
12. Direct effects of arsenic trioxide on action potentials in isolated cardiac tissues: importance of the choice of species, type of cardiac tissue and perfusion time.
Lu HR; Vlaminckx E; Cools F; Gallacher DJ
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):135-44. PubMed ID: 22445855
[TBL] [Abstract][Full Text] [Related]
13. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?
Carlsson L; Amos GJ; Andersson B; Drews L; Duker G; Wadstedt G
J Pharmacol Exp Ther; 1997 Jul; 282(1):220-7. PubMed ID: 9223557
[TBL] [Abstract][Full Text] [Related]
15. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential.
Orvos P; Kohajda Z; Szlovák J; Gazdag P; Árpádffy-Lovas T; Tóth D; Geramipour A; Tálosi L; Jost N; Varró A; Virág L
Toxicol Sci; 2019 Apr; 168(2):365-380. PubMed ID: 30561737
[TBL] [Abstract][Full Text] [Related]
17. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes.
Peng S; Lacerda AE; Kirsch GE; Brown AM; Bruening-Wright A
J Pharmacol Toxicol Methods; 2010; 61(3):277-86. PubMed ID: 20153443
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.
Schram G; Zhang L; Derakhchan K; Ehrlich JR; Belardinelli L; Nattel S
Br J Pharmacol; 2004 Aug; 142(8):1300-8. PubMed ID: 15277312
[TBL] [Abstract][Full Text] [Related]
19. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration.
Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH
Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of antiarrhythmic agents on post-pause repolarization in cardiac Purkinje fibres.
Wyse KR; Bursill JA; Campbell TJ
Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):825-9. PubMed ID: 8911721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
